Your browser is out of date

With an updated browser, you will have a better Medtronic website experience. Update my browser now.

×

Skip to main content

 

Symposium

An intrepid solution for transfemoral treatment of mitral regurgitation

Learning objectives

Join this session to:

  • To learn more about the APOLLO EU trial and journey to date
  • To understand the latest data on the Early Feasibility TF trial
  • To understand which patients can best benefit from this treatment

Agenda

Session objectives - Alison Duncan

Intrepid Journey update - Michael Reardon

Intrepid EFS TF data summary - Timothy Byrne

Discussion and audience interaction - Alison Duncan​

Patient selection case review series - Didier Tchétché; Nicolas Van Mieghem; Ralph Stephan von Bardeleben

Discussion and audience interaction - Alison Duncan​ & panel

Session evaluation and key learnings - Alison Duncan

 

Speakers

Speaker image london valve congress 2023

Alison Duncan​

Speaker image london valve congress 2023

Didier Tchétché

Speaker image london valve congress 2023

Timothy Byrne

Speaker image london valve congress 2023

Ralph Stephan von Bardeleben

Speaker image london valve congress 2023

Michael Reardon

Speaker image london valve congress 2023

Nicolas Van Mieghem